Patient toxicity prediction: Identification of mucosal injury mediators using microarray technology [ 2009 - 2012 ]

Research Grant

Researchers: A/Pr Joanne Bowen (Principal investigator)

Brief description There is no effective way to identify all patients that will develop toxic side-effects during the course of their cancer treatment. Current pharmacogenetic testing is too narrow. This project aims to examine whole-genome profiles of patient blood to determine if risk markers of toxicity can be identified prior to beginning treatment. I will do this by comparing oesophageal cancer patients who go on to develop severe toxicity with those who only get mild treatment side-effects.

Funding Amount $AUD 292,639.10

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF